Found: 21
Select item for more details and to access through your institution.
Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.
- Published in:
- Current Osteoporosis Reports, 2009, v. 7, n. 4, p. 118, doi. 10.1007/s11914-009-0021-4
- By:
- Publication type:
- Article
Ibandronate treatment for osteoporosis: Rationale, preclinical and clinical development of extended dosing regimens.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 14, doi. 10.1007/s11914-006-0010-9
- By:
- Publication type:
- Article
Disorders Associated With Acute Rapid and Severe Bone Loss.
- Published in:
- Journal of Bone & Mineral Research, 2003, v. 18, n. 12, p. 2083, doi. 10.1359/jbmr.2003.18.12.2083
- By:
- Publication type:
- Article
Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat.
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 10, p. 1556, doi. 10.1002/jbmr.5650101018
- By:
- Publication type:
- Article
Rapamycin: A bone sparing immunosuppressant?
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 5, p. 760, doi. 10.1002/jbmr.5650100513
- By:
- Publication type:
- Article
AzaThioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 1, p. 132, doi. 10.1002/jbmr.5650100119
- By:
- Publication type:
- Article
Progression of Efficacy with Ibandronate.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1117, p. 273, doi. 10.1196/annals.1402.052
- By:
- Publication type:
- Article
Cellular and Molecular Consequences of Calcineurin Aα Gene Deletion.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1116, p. 216, doi. 10.1196/annals.1402.050
- By:
- Publication type:
- Article
Osteoporosis and Diabetes Mellitus.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2004, v. 5, n. 3, p. 261
- By:
- Publication type:
- Article
Nonsteroid Immune Modulators and Bone Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1068, n. 1, p. 284, doi. 10.1196/annals.1346.032
- By:
- Publication type:
- Article
Modeling of Serum C-Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1068, n. 1, p. 560, doi. 10.1196/annals.1346.058
- By:
- Publication type:
- Article
The detergent properties of bactericidal fatty acid derivatives.
- Published in:
- Journal of the American Oil Chemists' Society (JAOCS), 1943, v. 20, n. 9, p. 171, doi. 10.1007/BF02593121
- By:
- Publication type:
- Article
A new function for CD38/ADP-ribosyl cyclase in nuclear Ca<sup>2+</sup> homeostasis.
- Published in:
- Nature Cell Biology, 1999, v. 1, n. 7, p. 409, doi. 10.1038/15640
- By:
- Publication type:
- Article
Proton Pump Inhibitor Therapy and Hip Fracture Risk.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 24, p. 2947, doi. 10.1001/jama.296.24.2947
- By:
- Publication type:
- Article
Disintegration and Esophageal Irritation Profiles of Alendronate Formulations: Implications for Clinical Safety and Efficacy.
- Published in:
- Journal of Applied Research, 2005, v. 5, n. 2, p. 253
- By:
- Publication type:
- Article
Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 9, p. 951
- By:
- Publication type:
- Article
Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.
- Published in:
- Transplant International, 2005, v. 18, n. 9, p. 1028, doi. 10.1111/j.1432-2277.2005.00163.x
- By:
- Publication type:
- Article
Insulin resistance and bone: a biological partnership.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 4, p. 305, doi. 10.1007/s00592-018-1101-7
- By:
- Publication type:
- Article
Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186.
- Published in:
- 2016
- By:
- Publication type:
- Letter
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.
- Published in:
- 2016
- By:
- Publication type:
- journal article